Oncology Clinical Trials in Eugene, OR
As of July 2026, 49 paid clinical trials are recruiting for Oncology in Eugene, Oregon. Oncology trials evaluate immunotherapies, targeted therapies, antibody-drug conjugates, and combination regimens across solid tumors and blood cancers — from early-phase first-in-human studies to phase 3 registration trials. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
49 clinical trials for Oncology
·Clear filters·↓ Download CSVA Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
A Long-term Extension Study of PCI-32765 (Ibrutinib)
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
MYLUNG Consortium Part 3: Observational Study
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
About research studies in Eugene
Eugene has approximately 141 recruiting research studies across a wide range of therapeutic areas. Oregon hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Eugene
Researchers run research studies in Eugene, OR at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Oncology Associates of Oregon, P.C. | Advanced/Metastatic Non-Small Cell Lung Cancer, Advanced/Metastatic Urothelial Cancer, Breast Cancer | 13 |
| Oncology Associates of Oregon | Multiple Myeloma, Breast Neoplasms, Endometrial Adenocarcinoma | 10 |
| University of Oregon | Acculturative Stress, Aging, Autism Spectrum Disorder | 10 |
| Verum Research, LLC | Diabetic Macular Edema, DME, Diabetic Macular Edema (DME) | 7 |
| Willamette Valley Cancer Institute and Research Center | Breast Cancer, Carcinoma, Non-Small-Cell Lung, Chronic Myeloid Leukemia | 7 |
| Willamette Valley Cancer Institute | Acute Myeloid Leukemia (AML), Breast Neoplasms, Low Grade Serous Ovarian Cancer | 5 |
| Prevention Science Institute | Academic Achievement, Behavior Problems, Clinical High Risk for Psychosis (CHR) | 4 |
| Oncology Associates of Oregon, P.C.(Willamette Valley Cancer Institute) (WVCI) | Essential Thrombocythemia, Lung Neoplasm Malignant, Cervical Cancer | 4 |
| Chestnut Health Systems | Decision Making, Decision Making, Shared, Implementation Science | 3 |
| Oncology Associates Of Oregon, Pc | Non-small Cell Lung Cancer (NSCLC), Solid Tumors, Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma | 3 |
| Pacific Sports & Spine | Chronic Pain, Degenerative Conditions of the Lumbar Spine, Degenerative Disc Disease | 3 |
| Pacific Sports and Spine | Chronic Low-back Pain, Degenerative Disc Disease, Osteoarthritis Knee Pain | 3 |
| Verum Research LLC | Age-related Macular Degeneration (AMD), Epiretinal Membrane, Geographic Atrophy | 3 |
| Oncology Associates of Oregon PC | Early Breast Cancer, NSCLC, NSCLC (Advanced Non-small Cell Lung Cancer) | 2 |
| Oncology Associates of Oregon PC Willamette Valley Cancer Institute | Carcinoma, Non-Small-Cell Lung, Multiple Myeloma | 2 |
| Oncology Associates of Oregon Willamette Valley Cancer Center | Chronic Lymphocytic Leukemia, CLL, Small Lymphocytic Lymphoma | 2 |
| Pacific Clear Vision Institute | Astigmatism, Bacterial Keratitis, Ectasia of Cornea | 2 |
| Pacific Sports and Spine, LLC | Chronic Pain, Pain | 2 |
| Slocum Center for Orthopedics & Sports Medicine | Avascular Necrosis of Hip, Degenerative Joint Disease of Hip, Femoral Fracture | 2 |
| Slocum Research & Education Foundation | Avascular Necrosis, Dislocation, Hip, Femoral Neck Fractures | 2 |
| Willamette Valley Cancer Institute and Research Center - Eugene | Endometrial Cancer, Extensive Stage Small-cell Lung Cancer, Recurrent or Progressive Endometrial Cancer | 2 |
| 517 | Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer | 1 |
| Arts & Technology Academy | Depression, Disparities, Emotional Regulation | 1 |
| Brain Electrophysiology Laboratory Company | Machine Learning, Memory, Mild Cognitive Impairment | 1 |
| Cal Young Middle School | Depression, Disparities, Emotional Regulation | 1 |
Active & Upcoming Studies in Eugene (2026)
Recruiting trials in Eugene grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (65 active studies)
- Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma · Phase 3 · Immuneering Corporation
- Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309) · Phase 3 · Astellas Pharma Global Development, Inc.
Eye & vision (11 active studies)
- A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated · Phase 1, Phase 2 · Boehringer Ingelheim
- CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME · Phase 3 · EyePoint Pharmaceuticals, Inc.
Mental health & behavior (8 active studies)
- Prevent Language Delays and Disorders Among Children of Caregivers With Substance Use Disorders With Community Groups and Individualized Services · University of Oregon
- Testing Implementation Strategies to Scale-up a Multicomponent Continuum of Service Intervention for Families Involved in Systems With Parental Opioid and Methamphetamine Use · Chestnut Health Systems
Neurology & pain (7 active studies)
- Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain · Phase 3 · Saol Therapeutics Inc
- Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain · Boston Scientific Corporation
Diabetes & metabolic (2 active studies)
- Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) · Phase 2 · Sparrow Pharmaceuticals
- Repeated Far Infrared Sauna Bathing in Adults With Obesity · University of Oregon
Pediatric (2 active studies)
- Prevent Language Delays and Disorders Among Children of Caregivers With Substance Use Disorders With Community Groups and Individualized Services · University of Oregon
- Walk With Me (WWM) for Perinatal Grief · Oregon Research Behavioral Intervention Strategies, Inc.
Common conditions studied in Eugene
- Endometrial Cancer (8 active studies). Recruiting Endometrial Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Chronic Lymphocytic Leukemia (5 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Multiple Myeloma (5 active studies). Recruiting Multiple Myeloma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Fallopian Tube Cancer (4 active studies). Recruiting Fallopian Tube Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Non-Small Cell Lung Cancer (4 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
- Ovarian Cancer (4 active studies). Ovarian cancer research examines PARP inhibitors, maintenance therapies, and antibody-drug conjugates for recurrent and platinum-resistant disease.
Leading research sponsors in Eugene
- University of Oregon
- AbbVie
- Janssen Research & Development, LLC
- Merck Sharp & Dohme LLC
- Pfizer
Local regulations and guidelines
Clinical trials in Oregon are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Oregon research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Eugene. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Eugene
Hipa.ai aggregates every recruiting study in Eugene from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Eugene?
There are approximately 141 recruiting clinical trials in Eugene, Oregon listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Eugene pay participants?
Most recruiting trials in Eugene compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Eugene?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Eugene?
The most common conditions under active study in Eugene include Endometrial Cancer (8), Chronic Lymphocytic Leukemia (5), Multiple Myeloma (5), Fallopian Tube Cancer (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Eugene?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Eugene on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Eugene?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Eugene?
Recruiting research sites in Eugene include Oncology Associates of Oregon, P.C., Oncology Associates of Oregon, University of Oregon, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Eugene right now?
The largest active categories in Eugene are Cancer & tumors (65), Eye & vision (11), Mental health & behavior (8). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.